The Company is engaged in the development, manufacture, marketing, sale and distribution of brand and off-patent pharmaceutical products.


Updates from The Motley Fool

Latest updates on Allergan from Fool.com.


Stock Performance

AGN vs. S&P 500 | 2 Year Performance
View Interactive AGN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Allergan.
Current Price: $239.36
Prev Close: $238.68
Open: $238.42
Bid: $238.39
Ask: $241.00
Day's Range: $237.50 - $240.80
52wk Range: $195.50 - $322.68
Volume: 2,899,540
Avg Vol 3,128,786
Market Cap: $94.34B
P/E (ttm): 19.30
EPS (ttm): $12.37
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Allergan.
CAPS Rating 4 out of 5
 
406 Outperform
28 Underperform
CAPS All Stars
 
104 Outperform
5 Underperform

How do you think Allergan will perform against the market?



You pick for Allergan is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Brenton Saunders, CEO

70% Approve

Based on 57 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Allergan.

The Company is engaged in the development, manufacture, marketing, sale and distribution of brand and off-patent pharmaceutical products.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers